vs

Side-by-side financial comparison of ACORN ENERGY, INC. (ACFN) and COMPUGEN LTD (CGEN). Click either name above to swap in a different company.

COMPUGEN LTD is the larger business by last-quarter revenue ($3.5M vs $2.4M, roughly 1.5× ACORN ENERGY, INC.). ACORN ENERGY, INC. runs the higher net margin — 45.2% vs -410.1%, a 455.3% gap on every dollar of revenue. On growth, ACORN ENERGY, INC. posted the faster year-over-year revenue change (-32.6% vs -61.8%).

Acorn Energy Inc. is a NASDAQ-listed conglomerate investing in electricity generation and security. It was founded by George Morgenstern in 1984 as Decision Systems, Inc. and was taken public by Laidlaw Securities. The name was later changed to Data Systems and Software Inc. John Moore became CEO in 2006 and changed the name to Acorn Factor and later to Acorn Energy.

Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big compan...

ACFN vs CGEN — Head-to-Head

Bigger by revenue
CGEN
CGEN
1.5× larger
CGEN
$3.5M
$2.4M
ACFN
Growing faster (revenue YoY)
ACFN
ACFN
+29.1% gap
ACFN
-32.6%
-61.8%
CGEN
Higher net margin
ACFN
ACFN
455.3% more per $
ACFN
45.2%
-410.1%
CGEN

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
ACFN
ACFN
CGEN
CGEN
Revenue
$2.4M
$3.5M
Net Profit
$1.1M
$-14.5M
Gross Margin
80.1%
Operating Margin
11.7%
-475.1%
Net Margin
45.2%
-410.1%
Revenue YoY
-32.6%
-61.8%
Net Profit YoY
-79.5%
-54.7%
EPS (diluted)
$0.42
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACFN
ACFN
CGEN
CGEN
Q4 25
$2.4M
Q3 25
$2.5M
Q2 25
$3.5M
$3.5M
Q1 25
$3.1M
Q4 24
$3.5M
Q3 24
$3.0M
Q2 24
$2.3M
$9.3M
Q1 24
$2.1M
$2.6M
Net Profit
ACFN
ACFN
CGEN
CGEN
Q4 25
$1.1M
Q3 25
$252.0K
Q2 25
$720.0K
$-14.5M
Q1 25
$464.0K
Q4 24
$5.2M
Q3 24
$725.0K
Q2 24
$271.0K
$-9.4M
Q1 24
$65.0K
$7.3M
Gross Margin
ACFN
ACFN
CGEN
CGEN
Q4 25
80.1%
Q3 25
78.5%
Q2 25
74.9%
Q1 25
75.1%
Q4 24
72.4%
Q3 24
71.7%
Q2 24
73.2%
60.5%
Q1 24
74.6%
17.9%
Operating Margin
ACFN
ACFN
CGEN
CGEN
Q4 25
11.7%
Q3 25
6.4%
Q2 25
26.9%
-475.1%
Q1 25
19.5%
Q4 24
23.9%
Q3 24
24.8%
Q2 24
11.3%
-128.5%
Q1 24
3.7%
Net Margin
ACFN
ACFN
CGEN
CGEN
Q4 25
45.2%
Q3 25
10.2%
Q2 25
20.4%
-410.1%
Q1 25
15.0%
Q4 24
148.3%
Q3 24
23.8%
Q2 24
11.9%
-101.4%
Q1 24
3.0%
284.0%
EPS (diluted)
ACFN
ACFN
CGEN
CGEN
Q4 25
$0.42
Q3 25
$0.10
Q2 25
$0.28
$-0.16
Q1 25
$0.19
Q4 24
$2.08
Q3 24
$0.29
Q2 24
$0.11
$-0.10
Q1 24
$0.03
$89505618.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACFN
ACFN
CGEN
CGEN
Cash + ST InvestmentsLiquidity on hand
$4.5M
$35.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$8.3M
$50.3M
Total Assets
$13.3M
$106.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACFN
ACFN
CGEN
CGEN
Q4 25
$4.5M
Q3 25
$4.2M
Q2 25
$3.3M
$35.3M
Q1 25
$2.6M
Q4 24
$2.3M
Q3 24
$2.2M
Q2 24
$1.5M
$44.6M
Q1 24
$1.4M
$39.3M
Stockholders' Equity
ACFN
ACFN
CGEN
CGEN
Q4 25
$8.3M
Q3 25
$7.2M
Q2 25
$6.9M
$50.3M
Q1 25
$6.1M
Q4 24
$5.5M
Q3 24
$288.0K
Q2 24
$-451.0K
$58.3M
Q1 24
$-733.0K
$65.6M
Total Assets
ACFN
ACFN
CGEN
CGEN
Q4 25
$13.3M
Q3 25
$12.4M
Q2 25
$12.5M
$106.5M
Q1 25
$11.1M
Q4 24
$10.6M
Q3 24
$5.4M
Q2 24
$4.8M
$110.2M
Q1 24
$4.9M
$121.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACFN
ACFN
CGEN
CGEN
Operating Cash FlowLast quarter
$295.0K
$-18.6M
Free Cash FlowOCF − Capex
$-18.8M
FCF MarginFCF / Revenue
-530.8%
Capex IntensityCapex / Revenue
6.5%
Cash ConversionOCF / Net Profit
0.27×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACFN
ACFN
CGEN
CGEN
Q4 25
$295.0K
Q3 25
$895.0K
Q2 25
$629.0K
$-18.6M
Q1 25
$271.0K
Q4 24
$166.0K
Q3 24
$698.0K
Q2 24
$84.0K
$39.7M
Q1 24
$-43.0K
Free Cash Flow
ACFN
ACFN
CGEN
CGEN
Q4 25
Q3 25
Q2 25
$-18.8M
Q1 25
Q4 24
Q3 24
Q2 24
$39.7M
Q1 24
FCF Margin
ACFN
ACFN
CGEN
CGEN
Q4 25
Q3 25
Q2 25
-530.8%
Q1 25
Q4 24
Q3 24
Q2 24
428.3%
Q1 24
Capex Intensity
ACFN
ACFN
CGEN
CGEN
Q4 25
Q3 25
Q2 25
6.5%
Q1 25
Q4 24
Q3 24
Q2 24
0.4%
Q1 24
Cash Conversion
ACFN
ACFN
CGEN
CGEN
Q4 25
0.27×
Q3 25
3.55×
Q2 25
0.87×
Q1 25
0.58×
Q4 24
0.03×
Q3 24
0.96×
Q2 24
0.31×
Q1 24
-0.66×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACFN
ACFN

PG$2.2M94%
Other$143.0K6%

CGEN
CGEN

Segment breakdown not available.

Related Comparisons